Cardiovascular Risk Factors and Culprit Plaque Characteristics in Women With Acute Coronary Syndromes.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 11 2023
Historique:
received: 28 05 2023
revised: 22 08 2023
accepted: 23 08 2023
medline: 6 11 2023
pubmed: 19 9 2023
entrez: 18 9 2023
Statut: ppublish

Résumé

Outcomes after myocardial infarction in women remain poor. The number of cardiovascular risk factors in women increase with age, however the relation between risk factors and culprit plaque characteristics in this population is poorly understood. The aim of the study was to investigate the relation between risk factors and culprit plaque characteristics in women with acute coronary syndrome (ACS). A total of 382 women who presented with ACS and underwent pre-intervention optical coherence tomography imaging of the culprit lesion were included in this analysis. The culprit plaques were categorized as plaque rupture, plaque erosion or calcified plaque, and then stratified by age and risk factors. The predominant pathology of ACS was plaque erosion in young patients (<60 years), which decreased with age (p <0.001). Current smokers had a high prevalence of plaque rupture (60%) and lipid plaque (79%). Women with diabetes tended to have more lipid plaque (70%) even at a young age. In women with hyperlipidemia, the prevalence of lipid plaques was modest in younger ages, but rose gradually with age (p <0.001). An increasing age trend for lipid plaque was also observed in women with hypertension (p = 0.03) and current smokers (p = 0.01). In conclusion, early treatment of risk factors such as diabetes in young women might be important before accelerated progression of atherosclerosis begins as age advances. Clinical trial registration: http://www.clinicaltrials.gov, NCT01110538, NCT03479723 and NCT02041650.

Identifiants

pubmed: 37722196
pii: S0002-9149(23)00933-5
doi: 10.1016/j.amjcard.2023.08.152
pii:
doi:

Substances chimiques

Lipids 0

Banques de données

ClinicalTrials.gov
['NCT01110538', 'NCT03479723', 'NCT02041650']

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-20

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Jang received educational grants from Abbott Vascular and consulting fees from Svelte Medical Systems, Inc. The authors have no competing interests to declare.

Auteurs

Lena Marie Seegers (LM)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Doreen DeFaria Yeh (DD)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Malissa J Wood (MJ)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Taishi Yonetsu (T)

Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Yoshiyasu Minami (Y)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Makoto Araki (M)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Akihiro Nakajima (A)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Haruhito Yuki (H)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Tsunenari Soeda (T)

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.

Osamu Kurihara (O)

Cardiovascular Center, Nippon Medical School, Chiba Hokusoh Hospital, Inzai, Japan.

Takumi Higuma (T)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Shigeki Kimura (S)

Division of Cardiology, Kameda Medical Center, Kamogawa, Japan.

Tom Adriaenssens (T)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.

Holger M Nef (HM)

Department of Cardiology, University of Giessen, Giessen, Germany.

Hang Lee (H)

Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Iris McNulty (I)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Tomoyo Sugiyama (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.

Tsunekazu Kakuta (T)

Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.

Ik-Kyung Jang (IK)

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Kyung Hee University Hospital, Seoul, Korea. Electronic address: ijang@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH